Td Asset Management Inc Pacira Bio Sciences, Inc. Transaction History

Td Asset Management Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 08, 2019	SELL	$36.47 - $42.17 $557,991 - $645,201	-15,300 Closed	0 $0
Q4 2018 Feb 01, 2019	SELL	$41.31 - $52.16 $297,432 - $375,552	-7,200 Reduced 32.0%	15,300 $658,000
Q3 2018 Nov 01, 2018	SELL	$32.85 - $52.0 $154,395 - $244,400	-4,700 Reduced 17.28%	22,500 $1.11 Million
Q2 2018 Jul 31, 2018	SELL	$27.5 - $39.8 $52,250 - $75,620	-1,900 Reduced 6.53%	27,200 $872,000
Q1 2018 May 11, 2018	BUY	$29.98 - $46.35 $53,964 - $83,430	1,800 Added 6.59%	29,100 $906,000
Q4 2017 Feb 02, 2018	BUY	$31.85 - $46.95 $47,775 - $70,425	1,500 Added 5.81%	27,300 $1.25 Million
Q3 2017 Nov 09, 2017	BUY	$35.7 - $39.5 $921,060 - $1.02 Million	25,800	25,800 $969,000

263

50.4M

429K

391K

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $892M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Td Asset Management Inc with notifications on news.